In a sudden turn of events, Food and Drug Commissioner, Scott Gottlieb who used his position to tackle difficult health issues resigned on Tuesday, which will be effective in a month’s time, according to a report by The Washington Post.
As per the report, Gottlieb who has been commuting to Washington from his home in Connecticut said that he wanted to spend more time with his family.
“It was a very hard decision. This is the best job I will ever have. I’m leaving because I need to spend time with my family. I get home late Friday, work on weekends and come back to Washington on Sunday. I did the job 100 percent,” Gottlieb said in an interview.
The resignation was neither sought by the White House, nor it was expected and it came as a surprise to many as he had recently hired senior staff and has been actively looking into new initiatives.
Following The Washington Post report, Gottlieb issued a statement saying, “I’m immensely grateful to lead this wonderful agency, for the support of my friends and colleagues, and the strong support of Donald Trump and Health Secretary Azar. This has been a wonderful journey and parting is really hard.”
Trump subsequently tweeted that Scott Gottlieb had “done an absolutely terrific job” as commissioner, adding, “He and his talents will be greatly missed!”
The resignation took some of the senior FDA officials by surprise and his signature issue–Youth vaping –is being reviewed by the White House Office of Management and Budget. The plan which was prepared and introduced by Scott Gottlieb last fall aims to sharply restrict the sale of flavored e-cigarettes in an attempt to curb a surge in underage vaping.
Gottlieb was chosen by the Trump administration to work in the current role some two years ago, though he had worked as FDA’s Deputy Commissioner for Medical and Scientific Affairs from 2005 to 2007.